Demographic, pharmacologic, and periodontal variables for gingival overgrowth in subjects medicated with cyclosporin in the absence of calcium channel blockers

Journal of Periodontology

Volumn 78, Issue 2, 2007, Pages 254-261

  Oliveira Costa, Fernando ^a   Diniz Ferreira, Sérgio ^a   Pereira Lages, Eugênio José ^a   Costa, José Estáquio ^a   Dutra Oliveira, Alcione Maria Soares ^a   Miranda Cota, Luís Otávio ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Calcium channel blockers; Cyclosporin; Gingival overgrowth; Risk; Transplant recipients

Indexed keywords

ANTIINFLAMMATORY AGENT; AZATHIOPRINE; CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE;

ADULT; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; CHI SQUARE DISTRIBUTION; FEMALE; GINGIVA OVERGROWTH; HUMAN; INFLAMMATION; KIDNEY TRANSPLANTATION; MALE; NONPARAMETRIC TEST; REGRESSION ANALYSIS; TIME;

ADULT; ANTI-INFLAMMATORY AGENTS; AZATHIOPRINE; CALCIUM CHANNEL BLOCKERS; CHI-SQUARE DISTRIBUTION; CYCLOSPORINE; FEMALE; GINGIVAL OVERGROWTH; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; KIDNEY TRANSPLANTATION; MALE; PREDNISOLONE; REGRESSION ANALYSIS; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 33847782225     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2007.050445     Document Type: Article

References (36)

1. Miranda J, Brunet L, Roset P, Berini L, Farré M, Mendieta C, Prevalence and risk of gingival overgrowth in patients treated with diltiazem or verapamil. J Clin Periodontol 2005;32:294-298.
2. Thomason JM, Seymour RA, Ellis JS. Risk factor for gingival overgrowth in patients medicated with cyclosporin in the absence of calcium channel blockers. J Clin Periodontol 2005;32:273-279.
3. Ellis JS, Seymour RA, Taylor JJ, Thomason JM. Prevalence of gingival overgrowth in transplant patients immunosuppressed with tacrolimus. J Clin Periodontol 2004;31:126-131.
4. de Oliveira Costa F, Diniz Ferreira S, de Miranda Cota LO, da Costa JE, Aguiar MA. Prevalence, severity, and risk variables associated with gingival overgrowth in renal transplant subjects treated under tacrolimus or cyclosporin regimens. J Periodontol 2006;77:969-975.
5. American Academy of Periodontology. Drug-associated gingival enlargement. (Informational paper). J Periodontol 2004;75:1424-1431.
6. Vescovi P, Meleti M, Manfredi M, Merigo E, Pedrazzi G. Cyclosporin-induced gingival overgrowth: A clinical-epidemiological evaluation of 121 Italian renal transplant recipients. J Periodontol 2005;76:1259-1264.
7. Dunn CJ, Wagstaff AJ, Perry CM, Plosker GL, Goa KL. Cyclosporin: An updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral) in organ transplantation. Drugs 2001;61:1957-2016.
8. Seymour RA, Smith DG. The effect of a plaque control programme on the incidence and severity of cyclosporin-induced gingival changes. J Clin Periodontol 1991;18:107-110.
9. Brown RS, Sun P, Corio R, Bottomley WK. Nitrendipine-induced gingival hyperplasia: First case report. Oral Surg Oral Med Oral Pathol 1990;70:593-596.
10. Lombardi T, Fiore-Donno G, Belser V, Di Felice R. Felodipine-induced gingival hyperplasia: A clinical and histologic study. J Oral Pathol Med 1991;20: 89-92.
11. Jorgensen MG. Prevalence of amlodipine-related gingival hyperplasia. J Periodontol 1997;68:676-678.
12. Karpinia KA, Matt M, Fennell RS 3rd, Hefti AF. Factors affecting cyclosporin-induced gingival overgrowth in pediatric renal transplant recipients. Pediatr Dent 1996;18:450-455.
13. Bokenkamp A, Bohnhorst B, Beir C, Albers N, Offner G, Brodehl J. Nifedipine aggravates cyclosporine A-induced gingival hyperplasia. Pediatr Nephrol 1994; 8:181-185.
14. Margiotta V, Pizzo I, Pizzo G, Barbaro A. Cyclosporin-and nifedipine-induced gingival overgrowth in renal transplant patients: Correlations with periodontal and pharmacological parameters and HLA-antigens. J Oral Pathol Med 1996;25:128-134.
15. Afonso M, Bello OV, Shibli JA, Sposto MR. Cyclosporin A-induced gingival overgrowth in renal transplant patients. J Periodontol 2003;74:51-56.
16. Thomason JM, Seymour RA, Ellis JS, et al. Iatrogenic gingival overgrowth in cardiac transplantation. J Periodontol 1995;66:742-746.
17. Thomason JM, Seymour RA, Ellis JS, et al. Determinants of gingival overgrowth severity in organ transplant patients: An examination of the role of HLA phenotype. J Clin Periodontol 1996;23:628-634.
18. Thomason JM, Seymour RA, Rice N. The prevalence and severity of cyclosporin and nifedipine induced gingival overgrowth. J Clin Periodontol 1993;20:37-40.
19. King GN, Healy CM, Glover MT, et al. Prevalence and risk factors associated with leukoplakia, hair leukoplakia, erythematous candidiasis, and gingival hyperplasia in renal transplant recipients. Oral Surg Oral Med Oral Pathol 1994;78:718-726.
20. King GN, Fullinfaw R, Higgins TJ, Walker RG, Francis DM, Wiesinfeld D. Gingival hyperplasia in renal allograft recipients receiving cyclosporin-A and calcium antagonists. J Clin Periodontol 1993;20:286-293.
21. Wondimu B, Berg U, Modéer T. Renal function in cyclosporine-treated pediatric renal transplant recipients in relation to gingival overgrowth. Transplantation 1997;64:92-96.
22. James JA, Boomer S, Maxwell AP, et al. Reduction in gingival overgrowth associated with conversion from cyclosporin A to tacrolimus. J Clin Periodontol 2000; 27:144-148.
23. Thomas DW, Newcombre RG, Osborne GR. Risk factors in the development of cyclosporine-induced gingival overgrowth. Transplantation 2000;69:522-526.
24. Daley TD, Wysocki GP, Day C. Clinical and pharmacologic correlations in cyclosporine-induced gingival hyperplasia. Oral Surg Oral Med Oral Pathol 1986;62: 417-421.
25. Spratt H, Boomer S, Irwin CR, et al. Cyclosporin associated gingival overgrowth in renal transplant recipients. Oral Dis 1999;5:27-31.
26. Friskopp J, Klintmalm G. Gingival enlargement: A comparison between cyclosporine and azathioprine treated renal allograft recipients. Swed Dent J 1986; 10:85-92.
27. McGaw T, Lam S, Coates J. Cyclosporin-induced gingival overgrowth: Correlation with dental plaque scores, gingivitis scores, and cyclosporin levels in serum and saliva. Oral Surg Oral Med Oral Pathol 1987;64:293-297.
28. Seymour RA, Heasman PA. Drugs and the periodontium. J Clin Periodontol 1988; 15:1-16.
29. Somacarrera ML, Hernandez G, Acero J, Moskow BS. Factors related to the incidence and severity of cyclosporine-induced gingival overgrowth in transplant patients: A longitudinal study. J Periodontol 1994;65: 671-675.
30. Thomas DW, Baboolal K, Subramanian N, Newcombe RG. Cyclosporin A-induced gingival overgrowth is unrelated to allograft function in renal transplant recipients. J Clin Periodontol 2001;28:706-709.
31. Wilson RF, Morel A, Smith D, et al. Contribution of individual drugs to gingival overgrowth in adult and juvenile renal transplant patients treated with multiple therapy. J Clin Periodontol 1998;25:457-464.
32. Pernu HE, Pernu LMH, Huttunen KRH, Nieminen PA, Knuuttila LE. Gingival overgrowth among renal transplant recipients related to immunosuppressive medication and the possible local background factors. J Periodontol 1992;63:548-553.
33. Seymour RA, Smith DG. The comparative effects of azathioprine and cyclosporine on some gingival health parameters of renal transplant patients: A longitudinal study. J Clin Periodontol 1987;14:610-613.
34. Silness J, Löe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964;22:121-135.
35. Saxer UP, Muhlemann HR. Motivation and education (in German). SSO Schweiz Monatsschr Zahnheilkd 1975;85:905-919.
36. Seymour RA, Smith DG, Turnbull DN. The effects of phenytoin and valproate on the periodontal health of adult epileptic patients. J Clin Periodontol 1985;12: 413-419.